SoloPharm attracts project finance from VTB North West

Pollyanna Capital Partners, the mid market Investment Bank, has acted as exclusive financial adviser to SoloPharm on arranging a Ruble 1,2 Billion project finance facility from VTB North West.

About SoloPharm

Company objectives:

• Saturation of Russian market with I.v. solutions at the European level.
• Launch of import-substituting products that are highly competitive to European analogues.
• Research and advanced development work.
• Development of safe, modern and high technology production plant for liquid dosage forms, that will comply with international standards of GMP and FDA.